Peripheral Artery Disease (PAD)
Also known as: Disease, Peripheral Artery / Peripheral Artery Disease / Artery Disease, Peripheral / Peripheral Artery Disease(PAD) / Peripheral Artery Diseases / Artery Diseases, Peripheral / Peripheral Artery Disease, PAD / PAD - Peripheral Arterial Disease / Peripheral Arterial Disease - PAD / Peripheral Arterial Disease(PAD) / Peripheral Arterial Disease (PAD) / Peripheral Arterial Disease / Peripheral Arterial Diseases / Peripheral arterial disease (disorder) / Chronic limb ischemia / Chronic limb ischaemia / Peripheral obliterative arteriopathy / Peripheral arterial occlusive disease / Peripheral arterial occlusive disease (disorder) / Peripheral vascular disease, unspecified / Peripheral Vascular Diseases / Circulatory disorder peripheral / Peripheral vascular disease (disorder) / Peripheral vascular disease / Peripheral vascular disease NOS / Peripheral vascular disorder / Disorder peripheral vascular / Vascular disorder peripheral / Disorder vascular peripheral / Peripheral vascular disorder NOS
Drug | Drug Name | Drug Description |
---|---|---|
DB00568 | Cinnarizine | A drug used for the management of labyrinthine disorder symptoms, including vertigo, tinnitus, nystagmus, nausea, and vomiting. |
DB00758 | Clopidogrel | An antiplatelet agent used to prevent blood clots in peripheral vascular disease, coronary artery disease, and cerebrovascular disease. |
DB00227 | Lovastatin | An HMG-CoA reductase inhibitor used to lower LDL cholesterol and reduce the risk of cardiovascular disease and associated conditions, including myocardial infarction and stroke. |
DB00806 | Pentoxifylline | A methylxanthine derivative used to treat intermittent claudication caused by chronic occlusive arterial disease of the limbs. |
DB06228 | Rivaroxaban | A factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations. |
DB09030 | Vorapaxar | A platelet aggregation inhibitor used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). |